Payment overview · 2025
General Payments
$294.02
15 reported records · 10 companies
Healthcare provider profile · identity verified
Abraham Thomas, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CLIFTON, IL · NPI 1063423655
Verified facts
What the public records show
CMS Open Payments records show Abraham Thomas, MD received $294.02 in general payments during 2025 across 15 reported records.
ABBVIE INC. accounted for 24.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 14 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti, Rybelsus.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 47 claims for Synthroid by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 218 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $70.49 | 24.0% | 4 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $35.82 | 12.2% | 2 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $32.94 | 11.2% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $30.51 | 10.4% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $28.73 | 9.8% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $26.48 | 9.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $21.40 | 7.3% | 1 | 2025 |
| Almatica Pharma LLC | Unresolved — no canonical attribution shown | $17.43 | 5.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $16.62 | 5.7% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $13.60 | 4.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $294.02 | 15 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $37.68 | 2 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $37.68 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $35.82 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $35.82 | 2 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $32.94 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $32.81 | 2 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $30.51 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.73 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $26.48 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $21.40 | 1 | 2025 |
Source payment records
|
|||||
| LOREEV XR Normalized: loreev xr |
Drug | Almatica Pharma LLC | $17.43 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $16.62 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $16.62 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $13.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 218 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 34 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
47 | 14 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
218 | 40 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
34 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1454 | 325 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1107 | 222 |
| Gabapentin | Gabapentin | 853 | 168 |
| Amlodipine Besylate | Amlodipine Besylate | 778 | 191 |
| Lisinopril | Lisinopril | 730 | 178 |
| Pantoprazole Sodium | Pantoprazole Sodium | 677 | 173 |
| Eliquis | Apixaban | 601 | 71 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 600 | 112 |
| Metoprolol Tartrate | Metoprolol Tartrate | 560 | 126 |
| Furosemide | Furosemide | 545 | 130 |
| Losartan Potassium | Losartan Potassium | 530 | 144 |
| Omeprazole | Omeprazole | 486 | 121 |
| Metformin Hcl | Metformin Hcl | 468 | 119 |
| Carvedilol | Carvedilol | 439 | 91 |
| Donepezil Hcl | Donepezil Hcl | 433 | 91 |
| Potassium Chloride | Potassium Chloride | 432 | 100 |
| Metoprolol Succinate | Metoprolol Succinate | 422 | 107 |
| Alprazolam | Alprazolam | 385 | 68 |
| Tamsulosin Hcl | Tamsulosin Hcl | 376 | 95 |
| Glimepiride | Glimepiride | 364 | 85 |
| Sertraline Hcl | Sertraline Hcl | 361 | 79 |
| Clopidogrel | Clopidogrel Bisulfate | 356 | 80 |
| Hydrochlorothiazide | Hydrochlorothiazide | 352 | 83 |
| Simvastatin | Simvastatin | 321 | 73 |
| Allopurinol | Allopurinol | 294 | 56 |
| Mirtazapine | Mirtazapine | 288 | 46 |
| Trazodone Hcl | Trazodone Hcl | 287 | 67 |
| Duloxetine Hcl | Duloxetine Hcl | 283 | 62 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 239 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 235 | 57 |
| Jardiance | Empagliflozin | 234 | 37 |
| Memantine Hcl | Memantine Hcl | 233 | 37 |
| Montelukast Sodium | Montelukast Sodium | 226 | 59 |
| Ozempic | Semaglutide | 218 | 40 |
| Tramadol Hcl | Tramadol Hcl | 215 | 52 |
| Escitalopram Oxalate | Escitalopram Oxalate | 192 | 37 |
| Meloxicam | Meloxicam | 187 | 37 |
| Xarelto | Rivaroxaban | 185 | 17 |
| Metformin Hcl Er | Metformin Hcl | 174 | 39 |
| Famotidine | Famotidine | 172 | 36 |
| Levetiracetam | Levetiracetam | 171 | 27 |
| Spironolactone | Spironolactone | 166 | 47 |
| Lorazepam | Lorazepam | 165 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 161 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 152 | 33 |
| Amiodarone Hcl | Amiodarone Hcl | 136 | 25 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 135 | 15 |
| Januvia | Sitagliptin Phosphate | 135 | 24 |
| Atenolol | Atenolol | 130 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 130 | 39 |
| Azithromycin | Azithromycin | 129 | 95 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 127 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 126 | 53 |
| Tizanidine Hcl | Tizanidine Hcl | 123 | 35 |
| Glipizide | Glipizide | 119 | 31 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 119 | 20 |
| Divalproex Sodium | Divalproex Sodium | 118 | 17 |
| Pregabalin | Pregabalin | 116 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 115 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 115 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 110 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 110 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 107 | 21 |
| Alendronate Sodium | Alendronate Sodium | 104 | 27 |
| Myrbetriq | Mirabegron | 100 | 11 |
| Clonazepam | Clonazepam | 98 | 19 |
| Baclofen | Baclofen | 97 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 96 | 17 |
| Methylprednisolone | Methylprednisolone | 94 | 53 |
| Ezetimibe | Ezetimibe | 90 | 30 |
| Doxycycline Hyclate | Doxycycline Hyclate | 88 | 63 |
| Sucralfate | Sucralfate | 88 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 85 | 57 |
| Zolpidem Tartrate | Zolpidem Tartrate | 82 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 81 | 43 |
| Warfarin Sodium | Warfarin Sodium | 75 | 21 |
| Buspirone Hcl | Buspirone Hcl | 74 | 19 |
| Latanoprost | Latanoprost | 74 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 72 | 17 |
| Entresto | Sacubitril/Valsartan | 72 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 71 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 71 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 70 | 34 |
| Prednisone | Prednisone | 70 | 27 |
| Diazepam | Diazepam | 68 | 15 |
| Nystatin | Nystatin | 67 | 33 |
| Risperidone | Risperidone | 67 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 65 | 42 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 14 |
| Klor-Con M20 | Potassium Chloride | 61 | suppressed |
| Topiramate | Topiramate | 61 | 17 |
| Tradjenta | Linagliptin | 61 | 11 |
| Trulicity | Dulaglutide | 61 | 11 |
| Ibuprofen | Ibuprofen | 59 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 57 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 57 | 17 |
| Lovastatin | Lovastatin | 56 | 11 |
| Finasteride | Finasteride | 55 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 55 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 53 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 52 | 16 |
| Metoclopramide Hcl | Metoclopramide Hcl | 52 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 51 | 14 |
| Farxiga | Dapagliflozin Propanediol | 51 | 13 |
| Incruse Ellipta | Umeclidinium Bromide | 49 | suppressed |
| Ondansetron Odt | Ondansetron | 48 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 12 |
| Temazepam | Temazepam | 48 | suppressed |
| Glipizide Er | Glipizide | 47 | 13 |
| Synthroid | Levothyroxine Sodium | 47 | 14 |
| Terazosin Hcl | Terazosin Hcl | 47 | 12 |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Bumetanide | Bumetanide | 45 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 45 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 45 | suppressed |
| Bupropion Xl | Bupropion Hcl | 44 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 44 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 42 | 35 |
| Lamotrigine | Lamotrigine | 42 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 32 |
| Irbesartan | Irbesartan | 41 | 11 |
| Sotalol | Sotalol Hcl | 41 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 40 | 18 |
| Albuterol Sulfate | Albuterol Sulfate | 39 | 16 |
| Brilinta | Ticagrelor | 39 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | 14 |
| Methotrexate | Methotrexate Sodium | 38 | suppressed |
| Fluconazole | Fluconazole | 37 | 21 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 37 | suppressed |
| Nitroglycerin | Nitroglycerin | 37 | 22 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 36 | 13 |
| Nabumetone | Nabumetone | 36 | 13 |
| Celecoxib | Celecoxib | 35 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 35 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | 12 |
| Rybelsus | Semaglutide | 34 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Metolazone | Metolazone | 33 | suppressed |
| Anastrozole | Anastrozole | 31 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 31 | suppressed |
| Lactulose | Lactulose | 30 | suppressed |
| Lidocaine | Lidocaine | 30 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | 11 |
| Valsartan | Valsartan | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 29 | suppressed |
| Insulin Lispro | Insulin Lispro | 29 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 29 | 16 |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 29 | suppressed |
| Novolog Flexpen | Insulin Aspart | 28 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Naproxen | Naproxen | 27 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 27 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 13 |
| Mounjaro | Tirzepatide | 26 | 11 |
| Ramipril | Ramipril | 26 | suppressed |
| Rytary | Carbidopa/Levodopa | 26 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 25 | suppressed |
| Cephalexin | Cephalexin | 25 | 19 |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Letrozole | Letrozole | 25 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | 14 |
| Gentamicin Sulfate | Gentamicin Sulfate | 24 | suppressed |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Torsemide | Torsemide | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Budesonide | Budesonide | 23 | suppressed |
| Carbamazepine | Carbamazepine | 23 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Gemtesa | Vibegron | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | 11 |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Folic Acid | Folic Acid | 21 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 21 | suppressed |
| Savella | Milnacipran Hcl | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | 12 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Klor-Con 10 | Potassium Chloride | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 16 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 18 | suppressed |
| Caplyta | Lumateperone Tosylate | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 13 |
| Nateglinide | Nateglinide | 18 | suppressed |
| Zonisamide | Zonisamide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Rexulti | Brexpiprazole | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Aztreonam | Aztreonam | 14 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Ertapenem | Ertapenem Sodium | 14 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 13 | suppressed |
| Clozapine Odt | Clozapine | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 11 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Corlanor | Ivabradine Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 12 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Flunisolide | Flunisolide | 12 | suppressed |
| Levemir | Insulin Detemir | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Avonex (4 Pack) | Interferon Beta-1a | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $294.02 · 15 records | ABBVIE INC. | Auvelity, Dexcom G6 Transmitter, INGREZZA, LOREEV XR, OTEZLA, Ozempic, QULIPTA, REPATHA, REXULTI, Rybelsus, The Cologuard Plus Collection Kit, UBRELVY, VRAYLAR, XIFAXAN | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error